RESVERLOGIX CORP (RVX.CA) Stock Price, Quote, News and Overview
TSX:RVX - Toronto Stock Exchange - CA76128M1086 - Common Stock - Currency: CAD
RVX.CA Quote, Performance and Key Statistics
TSX:RVX (7/25/2025, 7:00:00 PM)
0.135
-0.02 (-12.9%)
The current stock price of RVX.CA is 0.135 CAD. In the past month the price increased by 237.5%. In the past year, price increased by 170%.
RVX.CA Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| FRX.CA | FENNEC PHARMACEUTICALS INC | N/A | 331.16M | ||
| EPRX.CA | EUPRAXIA PHARMACEUTICALS INC | N/A | 271.50M | ||
| EDT.CA | SPECTRAL MEDICAL INC | N/A | 236.98M | ||
| TH.CA | THERATECHNOLOGIES INC | N/A | 199.09M | ||
| ONC.CA | ONCOLYTICS BIOTECH INC | N/A | 128.79M | ||
| WLLW.CA | WILLOW BIOSCIENCES INC | N/A | 119.59M | ||
| HBP.CA | HELIX BIOPHARMA CORP | N/A | 78.61M | ||
| COV.CA | COVALON TECHNOLOGIES LTD | 20.23 | 72.11M | ||
| MDNA.CA | MEDICENNA THERAPEUTICS CORP | N/A | 70.04M | ||
| MSCL.CA | SATELLOS BIOSCIENCE INC | N/A | 56.19M | ||
| BLU.CA | BLUENERGIES LTD | N/A | 54.52M | ||
| SVA.CA | SERNOVA BIOTHERAPEUTICS INC | N/A | 53.76M |
Related stock screener links
About RVX.CA
Company Profile
Resverlogix Corp. engages in the research and development of pharmaceutical products for cardiovascular diseases. The company is headquartered in Calgary, Alberta and currently employs 18 full-time employees. The company went IPO on 2001-10-12. The firm is engaged in epigenetics, with a focus on developing therapies for the benefit of patients with chronic diseases. Its epigenetic therapies are designed to regulate the expression of disease-causing genes. The firm's clinical program is focused on evaluating its lead candidate apabetalone (RVX-208) for the treatment of cardiovascular disease and associated comorbidities, and post-COVID-19 conditions. RVX-208 is a small molecule that is a selective bromodomain and extra-terminal (BET) inhibitor. BET bromodomain inhibition is an epigenetic mechanism that can regulate disease-causing genes. RVX-208 is a BET inhibitor selective for the second bromodomain (BD2) within the BET proteins. The company partners with EVERSANA, to support the commercialization of RVX-208 for cardiovascular disease, post-COVID-19 conditions, and pulmonary arterial hypertension in Canada and the United States.
Company Info
RESVERLOGIX CORP
300-4820 Richard Rd SW
Calgary ALBERTA T3E 6L1 CA
CEO: Donald J. McCaffrey
Employees: 19
Phone: 14032549252
RESVERLOGIX CORP / RVX.CA FAQ
What is the stock price of RESVERLOGIX CORP today?
The current stock price of RVX.CA is 0.135 CAD. The price decreased by -12.9% in the last trading session.
What is the ticker symbol for RESVERLOGIX CORP stock?
The exchange symbol of RESVERLOGIX CORP is RVX and it is listed on the Toronto Stock Exchange exchange.
On which exchange is RVX.CA stock listed?
RVX.CA stock is listed on the Toronto Stock Exchange exchange.
What is RESVERLOGIX CORP worth?
RESVERLOGIX CORP (RVX.CA) has a market capitalization of 38.38M CAD. This makes RVX.CA a Nano Cap stock.
How many employees does RESVERLOGIX CORP have?
RESVERLOGIX CORP (RVX.CA) currently has 19 employees.
What are the support and resistance levels for RESVERLOGIX CORP (RVX.CA) stock?
RESVERLOGIX CORP (RVX.CA) has a resistance level at 0.14. Check the full technical report for a detailed analysis of RVX.CA support and resistance levels.
Should I buy RESVERLOGIX CORP (RVX.CA) stock?
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
- The Technical Analysis (TA) tab contains a technical analysis of RVX.CA, looking at technical quality and support and resistance levels
- The Fundamental Analysis (FA) tab contains a fundamental analysis of RVX.CA, evaluating the profitability, health, valuation and growth aspects
- RESVERLOGIX CORP (RVX.CA) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
- RESVERLOGIX CORP (RVX.CA) Sales and EPS estimates to see what analysts future expectations are.
- RESVERLOGIX CORP (RVX.CA) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
- RESVERLOGIX CORP (RVX.CA) Insider and Institutional Ownership to learn about the owners and their transactions.
- RESVERLOGIX CORP (RVX.CA) Stock Chart to make your own analysis
- RESVERLOGIX CORP (RVX.CA) Latest news and press-releases to stay up to date.
Does RESVERLOGIX CORP (RVX.CA) stock pay dividends?
RVX.CA does not pay a dividend.
When does RESVERLOGIX CORP (RVX.CA) report earnings?
RESVERLOGIX CORP (RVX.CA) will report earnings on 2025-08-19.
What is the Price/Earnings (PE) ratio of RESVERLOGIX CORP (RVX.CA)?
RESVERLOGIX CORP (RVX.CA) does not have a PE ratio as the earnings reported over the last twelve months were negative (-0.07).
RVX.CA Technical Analysis
ChartMill assigns a technical rating of 8 / 10 to RVX.CA. When comparing the yearly performance of all stocks, RVX.CA is one of the better performing stocks in the market, outperforming 98.18% of all stocks.
RVX.CA Financial Highlights
Over the last trailing twelve months RVX.CA reported a non-GAAP Earnings per Share(EPS) of -0.07. The EPS decreased by -30.39% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -181.84% | ||
| ROE | N/A | ||
| Debt/Equity | N/A |
RVX.CA Ownership and Analysts
ChartMill assigns a Buy % Consensus number of 80% to RVX.CA. The Buy consensus is the average rating of analysts ratings from 5 analysts.